🇺🇸 FDA
Pipeline program

5 mg/500 mg METAGLIP™ Tablets

R04-0477

Phase 1 small_molecule completed

Quick answer

5 mg/500 mg METAGLIP™ Tablets for Healthy is a Phase 1 program (small_molecule) at TEVA PHARMACEUTICAL INDUSTRIES LTD with 1 ClinicalTrials.gov record(s).

Program details

Company
TEVA PHARMACEUTICAL INDUSTRIES LTD
Indication
Healthy
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials